Meeting
2012 ASCO Annual Meeting
Methylations of NEUROG1, p16, and MLH1 and recurrence following adjuvant FOLFOX in colorectal cancer.
Authors
Hyun-Jung Lee
Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
Hyun-Jung Lee , Sae-Won Han , Jeong Mo Bae , Nam-Yun Cho , Kyung-Hun Lee , Do-Youn Oh , Seock-Ah Im , Yung-Jue Bang , Seung-Yong Jeong , Kyu Joo Park , Jae-Gahb Park , Gyeong Hoon Kang , Tae-You Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Citation
J Clin Oncol 30, 2012 (suppl; abstr 3624)
DOI
10.1200/jco.2012.30.15_suppl.3624
Abstract #
3624
Poster Bd #
37E
Abstract Disclosures
Similar Posters
Poster
2015 Gastrointestinal Cancers Symposium
Evaluation of the CpG island methylator phenotype as a predictive biomarker for adjuvant oxaliplatin-based chemotherapy in colorectal cancer.
First Author: Stacey Shiovitz
Poster
2013 ASCO Annual Meeting
Effect of adding oxaliplatin to adjuvant 5-fluorouracil/leucovorin (5FU/LV) in patients with defective mismatch repair (dMMR) colon cancer stage II and III included in the MOSIAC study.
First Author: Jean-François Flejou
Poster
2011 ASCO Annual Meeting
CpG island methylator phenotype and KRAS mutation status as prognostic markers in patients with resected colorectal cancer.
First Author: D. H. Koo
Poster
2023 ASCO Annual Meeting
A novel genetic marker of fluoropyrimidine-induced cardiovascular toxicity.
First Author: Claire Palles